CalciTech Appoints MD for European Operations
14 2월 2012 - 7:42PM
Business Wire
CalciTech Ltd. (OTCBB: CLK) announces today the
appointment of Michael Watts as Managing Director of CalciTech
Synthetic Minerals Europe Limited (“CSME”), its UK based
wholly-owned European operating subsidiary. The acting Managing
Director, Michael Brickell, will now become a non-executive
director. CSME has an independent UK board of directors and senior
management with extensive commercial, industrial and financial
experience, and will operate independently within Europe. CSME will
be responsible for building the first SCC production plants in
Europe and making product available to the market.
Mr. Watts has a strong track record in bringing new technologies
to commercialisation. Previously on the Boards of Alpine Venture
Partners and BTG S.A., both of Switzerland, he most recently spent
6 years as President and CEO of the BTG Group, a multinational
company owned by Spectris plc with €100 million in sales and 450
employees. BTG provides instrumentation and consumable products to
the pulp and paper industry. While at BTG, he led the Company's
development into becoming a highly profitable operation despite
adverse market conditions.
Prior to BTG, Mr. Watts held several senior positions with
various companies such as President of Beta Lasermike Inc. (a
Spectris company), Raychem Corporation of Menlo Park California
(now Tyco Electronics), and Beecham Pharmaceuticals (now
GlaxoSmithKline). A physicist by training, Mr. Watts holds an MBA
from INSEAD.
Roger Leopard, CEO of CalciTech Limited said: “I’m delighted
that Michael Watts has joined CSME at this time as his ability,
experience and knowledge will drive the implementation of CSME’s
business plan.”
About CalciTech Ltd:
CalciTech Ltd has developed and patented unique technology for
the production of Synthetic Calcium Carbonate, “SCC” a specialty
material that may be widely used in industrialised parts of the
world and is developing operating licensees in these territories,
the first being in Europe. With its technological capabilities,
CalciTech will continue to develop the product potential into other
areas.
About CalciTech Synthetic Minerals Europe Ltd:
The Company, recently established in England, has been granted
an exclusive license for Europe to execute on the business plan to
develop the use of SCC specialty products within the high end
valued segments of paper, paint, polymer and related areas, food
and pharma applications. These producers and their customers also
want to improve the sustainability of their processes by using raw
materials that have been recycled, absorb CO2 and have a lower
carbon footprint. The first two plants have been designed and sites
identified in Germany. CSME, independently managed, is seeking
funding through the London market for investment in Europe.
The directors of the Company take responsibility for this
announcement.
Forward Looking Comments: The statements contained in this
release that are not historical facts are forward-looking
statements based on management's current expectations and beliefs
concerning future developments and their potential effects on the
Company. There can be no assurance that future developments
affecting the Company will be those anticipated by management.
Actual results may differ from those projected in the
forward-looking statements. These forward-looking statements
involve risks and uncertainties. Readers should refer to the risks
disclosures in the company's public filings with the Securities and
Exchange Commission (www.edgar.sec.gov) or on the
Company’s website.
Calci Tech (CE) (USOTC:CLKTF)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Calci Tech (CE) (USOTC:CLKTF)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024